Found 5 matching trials
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) PHASE3 The purpose of this study is to evaluate the safety and efficacy of zipaler...
Show More Status
Active Not Recruiting
Location
Comprehensive Cancer Centers of Nevada - Henderson
Learn More & Join Trial
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer PHASE2 This phase II trial tests how well zipalertinib with carboplatin and pemetr...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation. PHASE2 The purpose of this study is to evaluate the safety, efficacy and pharmacok...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection PHASE3 The purpose of this study is to compare the efficacy of zipalertinib versus...
Show More Status
Active Not Recruiting
Location
Alaska Oncology and Hematology
Learn More & Join Trial
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer PHASE1 CLN-081-001 is a Phase 1/2, open label, multi-center study of CLN-081 in pa...
Show More Status
Active Not Recruiting
Location
Pacific Cancer Medical Center, Inc
Learn More & Join Trial